WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) announces program topics planned for the BIO CEO & Investor Conference to be held February 13-14, 2012 at the Waldorf=Astoria in New York City, NY.
“As the biotech industry continues to innovate and grow, developing new therapeutics that will better the world, meetings like this play a key role in generating the investment interest that will help bring new therapies to market,” said Alan Eisenberg, BIO’s Executive Vice President of Emerging Companies and Business Development. “Investors from around the world will be in attendance to meet the most promising publically traded biotechnology companies in the industry.”
